First, the expression level of Prp19 in different neuroblastoma cell lines [SK-N-BE (2), SK-N-AS, SH-SY5Y, IMR32, and LAN1] was assessed, and the silencing efficiency of siRNA targeting Prp19 was examined (Figures 3A,B). This evidence concerns the gene PRPF19 and neuroblastoma.